CARDLYTICS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-103.5M | $-189.3M | $-134.7M | $-465.3M | $-128.6M | $-55.4M | $-17.1M | $-53.0M |
| Depreciation & Amortization | $25.2M | $25.7M | $26.5M | $37.5M | $29.9M | $7.8M | $4.5M | $3.3M |
| Depreciation | $1.0M | $1.8M | $3.7M | $5.4M | $6.7M | $5.6M | $4.0M | $3.0M |
| Amortization | $5.8M | $9.8M | $13.6M | $25.0M | $19.7M | — | — | — |
| Stock-Based Compensation | $28.1M | $40.4M | $41.0M | $44.7M | $50.3M | $32.4M | $15.9M | $26.8M |
| Net Cash from Operating Activities | $9.3M | $-8.8M | $-185.0K | $-53.9M | $-38.5M | $-7.6M | $11.5M | $-19.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $480.0K | $1.6M | $667.0K | $1.2M | $3.1M | $5.4M | $8.3M | $5.9M |
| Business Acquisitions | — | $0 | $0 | $2.3M | $494.1M | $0 | $0 | — |
| Net Cash from Investing Activities | $-15.3M | $-18.7M | $-10.1M | $-15.8M | $-506.7M | $-10.1M | $-11.0M | $-7.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | $0 | $0 | $40.0M | $0 | $0 | — | — |
| Net Cash from Financing Activities | $-11.1M | $1.4M | $-20.0M | $-40.0M | $486.0M | $206.4M | $44.2M | $65.2M |
| Net Change in Cash | $-16.9M | $-26.2M | $-30.2M | $-111.6M | $-59.8M | $188.8M | $44.7M | $38.6M |
| Free Cash Flow | $8.8M | $-10.4M | $-852.0K | $-55.1M | $-41.6M | $-13.0M | $3.2M | $-24.9M |